Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Héctor
Héctor Acosta-Salmón, La Paz MX
| Patent application number | Description | Published |
|---|---|---|
| 20100251968 | Methods for Producing Cultured Pearls in Conch and Other Gastropods - The subject invention provides methods for producing cultured pearls in gastropods, such as the queen conch, | 10-07-2010 |
Héctor Acosta-Salmón, La Paz MX
| Patent application number | Description | Published |
|---|---|---|
| 20100251968 | Methods for Producing Cultured Pearls in Conch and Other Gastropods - The subject invention provides methods for producing cultured pearls in gastropods, such as the queen conch, | 10-07-2010 |
Héctor Armendáriz Herrera, Mexico City MX
| Patent application number | Description | Published |
|---|---|---|
| 20120040822 | Non-destructive process for the elimination of silicon from alumina based materials - The present invention refers to a method for eliminating silicon or silicon compounds that are contained in alumina based materials without destroying such alumina based materials allowing for their reutilization, its main application is being the regeneration of alumina based catalyst contaminated with silicon, which are used in hydro-treating processes in the oil industry for sulfur elimination and silicon removal from process streams. It is important to note that the procedures and/or conventional methods known so far for the elimination and removal of silicon contained in alumina based materials, use inorganic acids or their mixture in a digestion process which modifies the properties of alumina and of any other element contained in the material, thus destroying the alumina and disabling their reutilization. The non-destructive method of the present invention is characterized by the fact that an extraction agent depolymerize the silicon compounds deposited in alumina based materials, with no modification of the properties of the alumina based material and with no substantial modification of other materials o or on the metal content present in the alumina based material. The extraction agent used is an alcohol, preferably a polyol and more preferably glycerol, which is available needless of high grade of purity for its use. The silicon contained in alumina based materials, in which the non-destructive method of the present invention is used, is preferably found in inorganic structures such as oxide or silanol: Si—(OX) | 02-16-2012 |
Héctor Santana Milian, Ciudad De La Habana CU
| Patent application number | Description | Published |
|---|---|---|
| 20080312139 | Use of Pharmaceutical Composition Containing Epidermal Growth Factor (EGF) for Diabetic foot Amputation Prevention - The invention relates to the use of Epidermal Growth Factor (EGF) in a preferably-Injectable pharmaceutical composition which is administered by means of infiltration into and around chronic cutaneous ischaemic lesions in order to prevent diabetic foot amputation. Said composition can be administered to recently-created surgical surfaces damaged by the effect of acute reperfusion with oxygenated blood following prolonged ischaemia, thereby preventing further surgical procedures and favouring the preservation of the extremity. The aforementioned composition can be used to improve (i) the cell microenvironment, thereby increasing the reparative and defensive capacity and viability of the is tissues and (ii) the cicatrisation of cutaneous ischaemic lesions, thereby stimulating cell proliferation. The invention is suitable for use in human, veterinary and experimental medicine, specifically in vascular angiology and surgery, dermatology, burn treatment and reconstructive surgery and geriatric medicine. Said composition can be used for recalcitrant ulcers which are associated with lesions in the macro and/or microvasculature, patients with inadequate lymphatic and/or venous return and ulcers or other lesions which are difficult to cicatrise and/or heal. | 12-18-2008 |
| 20090304628 | STABILIZED PHARMACEUTICAL FORMULATIONS THAT CONTAIN THE INTERFERONS GAMMA AND ALPHA IN SYNERGISTIC PROPORTIONS - The present invention is related to stable pharmaceutical formulations to be applied by parenteral (liquids or freeze-dried), or topic way (gel, unguent or cream) that contain different quantities of the recombinant interferons gamma and alpha in synergistic proportions for the treatment of pathological events that contemplate the malignant or benign not-physiological growth of cells in tissue or organs. | 12-10-2009 |
Héctor Santana Milian, Ciudad De La Habana CU
| Patent application number | Description | Published |
|---|---|---|
| 20090304628 | STABILIZED PHARMACEUTICAL FORMULATIONS THAT CONTAIN THE INTERFERONS GAMMA AND ALPHA IN SYNERGISTIC PROPORTIONS - The present invention is related to stable pharmaceutical formulations to be applied by parenteral (liquids or freeze-dried), or topic way (gel, unguent or cream) that contain different quantities of the recombinant interferons gamma and alpha in synergistic proportions for the treatment of pathological events that contemplate the malignant or benign not-physiological growth of cells in tissue or organs. | 12-10-2009 |